

Primobolan Depot Spectrum Pharma
€110.00
Substance:Â Methenolone Enanthate
Concentration: 100 mg/ml
Presentation: 10 ml/vial
Manufacturer: Spectrum Pharma
- Description
- Reviews (0)
- Store Policies
- Inquiries
Description
Primobolan Depot SP – Methenolone Enanthate 100
Primobolan Depot SP by Spectrum Pharma is an injectable anabolic compound based on Methenolone Enanthate, widely recognized for its mild yet high-quality anabolic properties. This compound is especially known for supporting muscle preservation, definition, and a clean, dry physique.
Thanks to its enanthate ester, Methenolone offers a moderate active half-life of approximately 5–7 days, allowing for stable and controlled activity over time.
Key Characteristics of Primobolan Depot SP
-
Active Substance: Methenolone Enanthate
-
Concentration: 100 mg/ml
-
Manufacturer: Spectrum Pharma
-
Active Half-Life: 5–7 days
Performance Profile
Primobolan Depot SP is primarily associated with physique refinement rather than extreme mass gains, making it popular during cutting or maintenance phases:
-
Muscle Mass: 3/10
-
Cutting / Definition: 7/10
-
Strength Increase: 5/10
Its effects are often described as gradual, clean, and sustainable, with an emphasis on muscle quality over size.
Side Effect Profile (Reported Characteristics)
Methenolone Enanthate is known for a relatively mild side-effect profile compared to many anabolic compounds:
-
Water Retention: Low
-
Aromatization: None
-
Hepatotoxicity: Low
-
Acne: Reported in some users
-
Hair Loss (HBR): Possible, depending on individual sensitivity
Due to the absence of aromatization, estrogen-related effects are generally not associated with this compound.
Why Primobolan Depot SP Is Well Known
-
Supports muscle preservation during calorie restriction
-
Promotes a dry, defined, and aesthetic appearance
-
Does not convert to estrogen
-
Suitable for cutting and recomposition-focused phases
-
Known for its mild and controlled anabolic nature
General Inquiries
There are no inquiries yet.





Reviews
There are no reviews yet